Anoro ellipta and Spirometry abnormal - a phase IV clinical study of FDA data

Summary:

Spirometry abnormal is reported as a side effect among people who take Anoro ellipta (umeclidinium bromide; vilanterol trifenatate), especially for people who are male, 60+ old, also take Azathioprine, and have Asthma.

The phase IV clinical study analyzes which people have Spirometry abnormal when taking Anoro ellipta. It is created by eHealthMe based on reports of 16,408 people who have side effects when taking Anoro ellipta from the FDA, and is updated regularly.

What is Anoro ellipta?

Anoro ellipta has active ingredients of umeclidinium bromide; vilanterol trifenatate. eHealthMe is studying from 16,515 Anoro ellipta users. Check the latest studies of Anoro ellipta.

What is Spirometry abnormal?

Spirometry abnormal is found to be associated with 131 drugs and 94 conditions by eHealthMe. Check the latest studies of Spirometry abnormal.

On Jul, 07, 2026

16,408 people reported to have side effects when taking Anoro ellipta.
Among them, 27 people (0.16%) have Spirometry abnormal.

Could Anoro ellipta cause Spirometry abnormal?

Among these 27 people:

What is the gender of people who have Spirometry abnormal when taking Anoro ellipta? *

female: 0.0 %
male: 100 %

What is the age of people who have Spirometry abnormal when taking Anoro ellipta? *

What are other drugs people take besides Anoro ellipta? *

What are other side effects people have besides Spirometry abnormal? *

Wheezing (a high-pitched whistling sound made while you breath): 27 people, 100.00%
Productive Cough: 27 people, 100.00%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 27 people, 100.00%
Atherosclerosis (disorder of the arteries): 27 people, 100.00%
Conjunctivitis Allergic (inflammation of the conjunctiva due to allergy): 27 people, 100.00%
Nodule (a growth of abnormal tissue): 27 people, 100.00%
Normochromic Normocytic Anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits): 27 people, 100.00%
Mycotic Allergy (fungal allergy): 27 people, 100.00%
Thrombosis (formation of a blood clot inside a blood vessel): 27 people, 100.00%
Pulmonary Embolism (blockage of the main artery of the lung): 27 people, 100.00%

What are the existing conditions these people have? *

Asthma: 4 people, 14.81%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Anoro ellipta and have Spirometry abnormal?

- Check whether Spirometry abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Anoro ellipta:

Anoro ellipta (16,515 reports)

Spirometry abnormal treatments and more:

Spirometry abnormal (751 reports)

How severe was Spirometry abnormal and when was it recovered:

Spirometry abnormal in Anoro ellipta

Expand to all the drugs that have ingredients of umeclidinium bromide; vilanterol trifenatate:

Spirometry abnormal and drugs with ingredients of umeclidinium bromide; vilanterol trifenatate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Anoro ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Spirometry abnormal:

Spirometry abnormal (131 drugs)

Browse all the conditions that are associated with Spirometry abnormal:

Spirometry abnormal (94 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on umeclidinium bromide; vilanterol trifenatate (the active ingredients of Anoro ellipta) and Anoro ellipta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.